Open access · CC-BY
via OpenAlex
The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease
David C. Schöndorf, Dina Ivanyuk, Pascale Baden, Álvaro Sánchez-Martínez, Silvia De Cicco, Cong Yu, Ivana Giunta, Lukas K. Schwarz, Gabriele Di Napoli, Vasiliki Panagiotakopoulou, Sigrun Nestel, Marcus Keatinge, Jan Pruszak, Oliver Bandmann, Bernd Heimrich
Cell Reports · 2018 · ▲ 337 citations
Abstract
While mitochondrial dysfunction(definition) is emerging as key in Parkinson's disease (PD), a central question remains whether mitochondria are actual disease drivers and whether boosting mitochondrial biogenesis and function ameliorates pathology. We address these questions using patient-derived induced pluripotent stem cells and Drosophila models of GBA-related PD (GBA-PD), the most common PD genetic risk. Patient neurons display stress responses, mitochondrial demise, and changes in NAD+ metabolism. NAD+ precursors have been proposed to ameliorate age-related metabolic decline and disease. We report that increasing NAD+ via the NAD+ precursor nicotinamide riboside (NR) significantly ameliorates mitochondrial function in patient neurons. Human neurons require nicotinamide phosphoribosyltransferase (NAMPT) to maintain the NAD+ pool and utilize NRK1 to synthesize NAD+ from NAD+ precursors. Remarkably, NR prevents the age-related dopaminergic neuronal loss and motor decline in fly models of GBA-PD. Our findings suggest NR as a viable clinical avenue for neuroprotection in PD and other neurodegenerative diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.celrep.2018.05.009
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Schöndorf, D.C., Ivanyuk, D., Baden, P., Sánchez-Martínez, �., Cicco, S.D., Yu, C., Giunta, I., Schwarz, L.K., Napoli, G.D., Panagiotakopoulou, V., Nestel, S., Keatinge, M., Pruszak, J., Bandmann, O., Heimrich, B., Gasser, T., Whitworth, A.J., & Deleidi, M. (2018). The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease. <em>Cell Reports</em>. https://doi.org/10.1016/j.celrep.2018.05.009
Vancouver
Schöndorf DC, Ivanyuk D, Baden P, Sánchez-Martínez �, Cicco SD, Yu C, et al. The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease. Cell Reports. 2018. doi:10.1016/j.celrep.2018.05.009.
BibTeX
@article{david2018TheNAD,
title = {The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease},
author = {David C. Schöndorf and Dina Ivanyuk and Pascale Baden and Álvaro Sánchez-Martínez and Silvia De Cicco and Cong Yu and Ivana Giunta and Lukas K. Schwarz and Gabriele Di Napoli and Vasiliki Panagiotakopoulou and Sigrun Nestel and Marcus Keatinge and Jan Pruszak and Oliver Bandmann and Bernd Heimrich and Thomas Gasser and Alexander J. Whitworth and Michela Deleidi},
journal = {Cell Reports},
year = {2018},
doi = {10.1016/j.celrep.2018.05.009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · CC-BY
Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinson’s Disease
npj Metabolic Health and Disease 2025
Open access · CC-BY
The role of NAD+ metabolism and its modulation of mitochondria in aging and disease
Nature Communications 2016
Open access · CC-BY
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Research Square 2020
Preprint · CC-BY
Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinson’s Disease but does not impact sirtuin activity
Experimental Neurobiology 2015
Open access · OA
Mitochondrial Dysfunction in Parkinson’s Disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2009
Open access · OA